LINC01614 and breast carcinoma: The results demonstrated that breast cancer patients with increased levels of AC009686.2, AC132807.2, AC093515.1, AC129926.2, AL513123.1, RHPN1-AS1, KCNMB2-AS1, LINC01614, LINC01705, and C6orf99 had a better overall survival (Fig. 7A–J).